Day of Atonement

Yom Kippur is the holiest day in Judaism and Samaritanism, culminating the 10 Days of Awe, a period of introspection and repentance that follows Rosh Hashanah. Yom Kippur is when God decides each person's fate, and those participating are encouraged to make amends, asking forgiveness for sins committed during the past year so their name can be enshrined in the Book of Life. Fasting is a vehicle for reflecting and repenting sins. Let's take this time to appreciate the diversity of our community and the richness that different cultures and traditions bring to our organization. Wishing you peace and goodness during Yom Kippur. G'mar chatima tovah, may you be sealed in the Book of Life. (Yom Kippur begins at sunset on Sunday, September 24 and continues until sundown on Monday, September 25.)

Saturday, November 18 - Christiana Hilton, Newark

Registration is open for the 234th MSD Annual Meeting to be held on Saturday, November 18th. This year's meeting will be held at the Christiana Hilton in Newark. All MSD members are encouraged to attend. American Medical Association (AMA) President Jesse Ehrenfeld, MD, MPH will present remarks from the AMA. Thank you to our Council members for their service to MSD and their constituents.

Registration for this event is through the MSD education platform (Rievent), which most should be familiar with.

If you are NEW to this registration platform and have NOT utilized entering 5-digit codes for attending accredited education sessions in the past, then:

• You are considered a NEW USER and need to create a learner account in this electronic platform during the registration process.
• As a NEW USER: your username is the email you register with for the event. Please be sure to use a valid email address to receive pre- and post-meeting information, especially about CMEs!
• The account setup will take less than 5 minutes

If you have used the system before & already have an account, please login with your account information as an Existing User to register for this meeting.

Hint: When registering, please ensure that you disable browser extensions or add-ons to ensure any third-party firewall that was set up on your device/network lets you through to the site. Please also avoid using public/hospital Wi-Fi when accessing your account.

Things to know:

• The Inaugural Gala is on hold for this year. View the Annual Meeting agenda.
• There will be two education sessions: "Food as Medicine," and "Recipes for Healthy Living: Empowerment, Nutrition, Longevity."
• Delaware Medical Political Action Committee (DELPAC) members can enjoy gourmet coffee and conversation with Delaware lawmakers. Join DELPAC if you are not already a member.
• Resolutions are a vehicle to submit your issues to the Council. Resolutions must be submitted via email to Mary LaJudice no later than October 27th.
• When registering, please follow the guidelines above to sign in as a New User or an Existing User.

MSD thanks those supporting organizations that help make this event possible. Please consider them for your personal and professional needs.

Doctors Prayus and Jayshree Tailor

Congratulations to MSD members Prayus Tailor, MD, MSD Past President, and Jayshree Tailor, MD, Chair of MSD's School Health Subcommittee, for making the cover of the 2023 "Top Docs" issue of Delaware Today. MSD congratulates all physicians across Delaware who are highlighted in this issue. We think you all are Top Docs! If you are not a subscriber to Delaware Today Magazine, you can pick up a copy of the October 2023 Top Doctors issue where magazines are sold or consider a subscription for yourself! Picture courtesy of Delaware Today.

Safeguards Free COVID-19 Vaccination for Un- and Under-Insured Adults

In April, the Department of Health and Human Services (HHS) announced the "HHS Bridge Access Program For COVID-19 Vaccines and Treatments Program" to maintain broad access to COVID-19 vaccines for millions of uninsured Americans. Last week, the Bridge Access Program officially launched, providing continued free coverage for the estimated 25-30 million adults who would have otherwise lost access to affordable COVID-19 vaccines now that the distribution of vaccines has transitioned to the commercial market.

The updated COVID-19 vaccines will soon be available, if not already, at pharmacies, through health care professionals, state public health clinics, federally qualified health centers, and other facilities. Vaccination will be available free for everyone through one of three methods. Those covered under most private or government insurance plans can receive the vaccine at various pharmacies or health care professionals throughout the state with the cost fully covered by insurance. For those who are uninsured or underinsured, vaccinations will be available at federally qualified health centers (FQHCs), public health clinics, local pharmacies, and certain health care professionals via the State of Delaware’s Immunization Program and at Walgreens, CVS, and pharmacies affiliated with the ETrueNorth pharmacy network through the federal government’s Bridge Access Program. Additionally, children who currently participate in the CDC’s Vaccines for Children Program will also be able to receive free COVID-19 updated vaccines where they receive their routine vaccinations.  A full listing of vaccine locations will be posted on www.vaccines.gov as they become available.

The FDA has outlined the following brief guidelines for the updated COVID-19 vaccines to simplify the questions regarding whom should receive the vaccine and when: 

• Individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.  
• Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 vaccine received).  
• Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated authorized Moderna COVID-19 Vaccine. 

Every Household Can Place an Order for Delivery Directly to Home

Free at-home coronavirus tests have been harder to come by for many Americans now that private insurers are no longer required to cover up to eight tests per month. Looking ahead to a possible winter surge of COVID-19, it was announced that the program would be revived to offer Americans free coronavirus tests through the mail. The website for the program, covidtests.gov, will begin accepting orders on Monday, September 25th and households will receive four tests. Before throwing out "expired" tests, Check to see if your COVID-19 tests' expiration dates have been extended.

Reinstate Coverage for Impacted Individuals

Today, the U.S. Department of Health and Human Services (HHS) announced it has helped half a million children and families regain their Medicaid and Children’s Health Insurance (CHIP) coverage. On August 30, the Centers for Medicare & Medicaid Services (CMS) issued a call to action to states about a potential state systems issue where systems were inappropriately disenrolling children and other enrollees, even when the state had information indicating the person remained eligible. CMS sent a letter on August 30 to all states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands requiring them to determine and report whether they have a systems issue that inappropriately disenrolls children and families, even when the state had information indicating that they remained eligible for Medicaid and CHIP coverage. Today’s summary indicates that to-date 30 states report having this systems issue. As a result, to avoid CMS taking further action, all 30 states were required to pause procedural disenrollments for impacted people unless they could ensure all eligible people are not improperly disenrolled due to this issue.

Low Number of Donations Over the Summer

The Blood Bank of Delmarva declared a blood emergency following a summer of low donor turnout contributing to the shortage is a 50% decrease in youth donors since 2019. The region’s blood supply is well below the usual five to seven day supply. Delaware is not alone, as blood shortages are happening across the country, with multiple centers urgently calling for blood donations. While all blood types are needed, type O negative, O positive, and platelets are critically low. In addition to youth and first-time donors, the Blood Bank is also encouraging African American and Hispanic Americans to donate blood during Sickle Cell Awareness Month and Hispanic Heritage Month. African Americans comprise 22% to 30% of Delmarva’s population but are only 5% of total blood donors. One in three African American donors is a match for sickle cell patients who can require hundreds of transfusions each year. Hispanics comprise 10% of the local population and just 2% of blood donors with an estimated 60% have in-demand type O blood. The Blood Bank of Delmarva also asked recently relocated retirees to the state to donate blood. Local residents are asked to schedule an appointment by calling 1-888-8-BLOOD-8 or going to www.delmarvablood.org. Make a difference! Donate today!

FDA Clarifies Results of Recent Advisory Committee Meeting

The U.S. Food and Drug Administration (FDA) Non-prescription Drug Advisory Committee meeting discussed new data on the effectiveness of over-the-counter oral phenylephrine and concluded that the current scientific data do not support that the recommended dosage of orally administered phenylephrine is effective as a nasal decongestant. However, neither FDA nor the committee raised concerns about safety issues with use of oral phenylephrine at the recommended dose. If FDA determines that oral phenylephrine is not effective, the agency would first issue a proposed order removing phenylephrine from this product labeling (documented as an OTC monograph). The public would then have the opportunity to comment on the proposed order. If, after considering the comments, FDA continued to conclude phenylephrine is not effective, the agency would issue a final order removing this ingredient from the monograph, and phenylephrine would no longer be considered generally recognized as safe and effective (GRASE). FDA would then work closely with manufacturers to reformulate products as needed to help ensure availability of safe and effective products to treat symptoms of colds or allergies.

Phenylephrine is also an ingredient in nasal sprays to treat congestion. The advisory committee’s discussion and recommendations only related to orally administered phenylephrine, and not the nasal spray form. Phenylephrine-containing nasal sprays will not be affected by any possible actions taken for phenylephrine in orally administered products (such as tablets or capsules that contain phenylephrine).

New Rule Reduces Hassle, Simplifies Medicare Savings Program Enrollment

The Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), on Monday finalized a rule to streamline enrollment in the Medicare Savings Programs (MSPs), making coverage more affordable for an estimated 860,000 people. The MSPs, run by state Medicaid programs, currently cover Medicare premiums and, in most cases, cost-sharing for more than 10 million older adults and people with disabilities who also have limited incomes. The MSPs provide vital links to coverage and care. However, only about half of eligible people are enrolled in the MSPs, in part due to cumbersome application and verification processes now simplified by this rule. For example, all Medicare-eligible individuals who receive Supplemental Security Income (SSI) are financially eligible for MSPs, but many are not enrolled because of burdensome and duplicative paperwork. Under the new final rule, many SSI recipients will now be enrolled automatically into the most comprehensive form of MSP coverage: the Qualified Medicare Beneficiary eligibility group, which covers Medicare premiums and cost sharing. Under the rule, states will also make better use of data from the Medicare Part D Low Income Subsidy (LIS) or “Extra Help” program, which helps many older adults and people with disabilities pay for prescription drugs and prescription drug coverage when they live on a limited income.

Community Response Briefing

On Tuesday this week, leaders from the Delaware Department of Health and Social Services (DHSS) joined partner community agencies for a community response briefing to provide the latest information regarding the state’s efforts to address disparities in outcomes related to Substance Use Disorder and Opioid Use Disorder for minority and vulnerable populations. Organized by the DHSS Division of Substance Abuse and Mental Health (DSAMH), these quarterly briefings aim to inform the public about the State’s ongoing work to reduce overdoses and respond to the opioid epidemic. The event was championed by Delaware Lt. Governor Bethany Hall-Long, Chair of the Behavioral Health Consortium, PhD, RN.

Reflects Prescription Drug Dispensing Trends in Delaware

The My Healthy Community (MHC) Dashboard includes a color-coded matrix of communities that may be at higher risk of Opioid Use Disorder (OUD). The matrix and other recent updates present prescription drug dispensing trends in Delaware. The Division of Public Health (DPH) and the Delaware Division of Professional Regulation Office of Controlled Substances made Prescription Monitoring Program (PMP) data publicly available. The agencies updated the Mental Health and Substance Use Disorder section’s PMP tab with funding from the Centers for Disease Control and Prevention’s Overdose Data to Action grant. The grant also funds the Delaware PMP. Indicators of a high need for treatment are the rate of prescriptions for high dose and extended-release opioids. These indicators are shown by count and rate of prescriptions and include data on the number of people filling those prescriptions. Trend data for filled prescriptions indicate a steady decline in dispensed opioids and an increase in OUD treatment medications. DPH continues to educate physicians and pharmacists on best practices for pain management. This includes offering one-on-one education and continuing education opportunities and working with Delaware health professionals to create educational materials for them and their and patients. DPH compiled an inventory of Delaware-specific, evidence-based pain management resources for prescribers and dispensers at Prescription Medications | Help is Here Delaware. For more information on acute pain management and alternatives to opioids for pain, read the CDC Clinical Practice Guideline for Prescribing Opioids for Pain published in 2022.

Early Signal of Changing Trends in Delaware's Opioid Overdose Epidemic

The Division of Public Health (DPH) added suspected drug overdose data to the My Healthy Community (MHC) data dashboard. It can be viewed on the Drug Overdose Deaths tab within MHC’s Mental Health and Substance Use Disorder section. The Centers for Disease Control and Disease Prevention Overdose Data to Action grant funded the addition, which was completed in collaboration with the Delaware Division of Forensic Science. Suspected drug overdose death counts are an early signal of changing trends in Delaware’s opioid overdose epidemic. Suspected drug overdose deaths based on forensic investigator scene impressions are reported to DPH within a week of occurrence and are considered preliminary until further tests are conducted. For free 24/7 counseling, coaching, and support, as well as links to mental health, addiction, and crisis services, citizens can call the Delaware Hope Line at 1-833-9-HOPEDE.

Hope is Real, Recovery is Real

As part of the Substance Abuse and Mental Health Services Administration's (SAMHSA’s) 2023 National Recovery Month efforts, SAMHSA’s Office of Recovery has released the Recovery from Substance Use and Mental Health Problems Among Adults in the United States Report.

Based on data from the National Survey on Drug Use and Health (NSDUH), an annual survey sponsored by SAMHSA, key findings from the report include:

• Recovery is real and possible – A significant majority (7 in 10) of adults who have had a mental health or substance use condition are in recovery and they represent over 50 million Americans.
• Recovery is holistic and personalized – Factors such as social supports, treatment, insurance coverage, and spirituality can be key in supporting recovery.
• Resilience can accompany recovery – People in recovery reported that their mental health and substance use were not significantly impacted by the COVID-19 pandemic.

Conducted annually, the NSDUH provides nationally representative data on the use of tobacco, alcohol, and drugs; substance use disorders; receipt of substance use treatment; mental health issues; and the use of mental health services among the civilian, noninstitutionalized population aged 12 or older in the United States. Spread the word! This September and always, hope is real, and recovery is real.

NIH Awards $5.8M for Early Career Researchers

The National Institutes of Health (NIH) will provide approximately $5.8 million over five years to create an educational hub for computational genomics and data science. The hub will provide new educational and research opportunities for students of diverse backgrounds, including those from groups historically underrepresented in the biomedical sciences. The hub will be based at North Carolina Agricultural and Technical State University (NCATSU), the largest historically Black college and university in the United States. The program will support educational activity at two different early career stages—undergraduate and master's degree level—to help students build a solid foundation in the field. In addition to funding from the National Human Genome Research Institute, this educational award is supported by the National Institute on Minority Health and Health Disparities, the NIH Office of Data Science Strategy, and the NIH All of Us Research Program.

Delaware Literacy Alliance's 2024-2027 Plan Unveiled

Governor John Carney and First Lady Tracey Quillen Carney on Tuesday this week recognized September as Literacy Month with a proclamation signing at the Wilmington Library. Literacy Month is intended to recognize the extensive efforts of literacy partners to promote reading as an essential skill and a lifelong pleasure. Governor Carney encouraged all Delawareans to take advantage of the many resources available in our state through Delaware’s libraries and literacy organizations this month and every month. Dr. Annie Norman, State Librarian, indicated, “Literacy is the foundation for success in school, in work, and throughout life.” The Delaware Chapter of the American Academy of Pediatrics is also working to promote early literacy in the state with projects in conjunction with Reach Out and Read. To learn more about First Chance Delaware, visit Governor Carney’s website. To view the Delaware Literacy Alliance’s strategic plan, visit the Delaware Libraries website. Follow the Delaware Libraries form to join the Delaware Literacy Alliance.

Zocdoc Launches Free Digital Tools to Improve Engagement, Activation

Zocdoc, a platform enabling patients to find and book in-person or virtual appointments, announced the release of a free suite of tools to help health care professionals reach and manage patient care more effectively. Called Zocdoc Practice Solutions, the suite includes intake tools that allow patients to fill out forms and send insurance information online ahead of the visit, online scheduling solutions that enable patients to view provider availability and book online directly from a practice's website or a search engine, and video services that will allow providers to see patients virtually with HIPAA-compliant video technology. These tools are available to all health care professionals, not just Zocdoc marketplace customers. Health care professionals can also use these tools to manage patients, including those who do not use Zocdoc. Any health care professional or practice is invited to sign up to use Zocdoc Practice Solutions — free of charge and available to use for their entire patient panel, not just Zocdoc bookers — at zocdoc.com/practicesolutions.

Check For Errors, Request a Review by October 9th

For the first time since the Medicare Merit-based Incentive Payment System (MIPS) started, there are alarming reports that physicians are facing penalties under the program. The Centers for Medicare & Medicaid Services (CMS) made available 2022 MIPS performance feedback in August. Performance in 2022 determines whether physicians will get a positive, neutral or negative payment adjustment on the Medicare services they deliver in 2024. These penalties can cut Medicare payment by as much as 9%. Check your MIPS performance feedback now on the Quality Payment Program website using your HCQIS Access Role and Profile (HARP) credentials. If there are any errors, you should consider submitting an appeal, also called a targeted review. The deadline to submit a targeted review is October 9th.

Embracing Family Friendly Benefits

In today’s work environment, the line between personal and professional life is becoming increasingly blurred. As a result, employees are seeking more comprehensive benefits that accommodate their family responsibilities and foster a healthy work-life balance. More employers today have begun to understand that an expansion of family-friendly benefits above and beyond federal law requirements is a key facet to protecting the physical and mental health of their workers. Family friendly benefits are essential in attracting and retaining top talent, as they demonstrate an organization’s commitment to supporting its employees beyond the workplace. Employers can utilize a few key strategies in order to effectively include family-friendly benefits in their employee benefit package, which can help lead to positive impacts on employee well-being, job satisfaction and overall organizational success. Read more.

The Medical Society of Delaware Insurance Services offers its members access to My Benefit Advisor as a solution for employee benefits, including voluntary offerings. For more information about My Benefit Advisor, visit our website at www.mybenefitadvisor.com or contact Sharon Ruth at (302) 397-0173.

Sharing Notes with Patients Can Improve Satisfaction, Education, Safety

Research shows physicians and other clinicians who share their notes with patients can improve patient satisfaction, education and safety. Increasing engagement with patients and their caregivers invariably means better medication adherence and can help patients remember recommended tests and immunizations.

LEARN MORE:

Toolkits:

• Sharing Clinical Notes
• Medication Adherence

AMA STEPS Forward^® offers a collection of engaging and interactive educational content designed to help put the joy back into medicine.

FREIDA Can Help!

Starting September 27, program directors begin reviewing MyERAS applications. Get prepared! Visit FREIDA™️, the AMA Residency and Fellowship Database®️, to review programs, finalize your top selections, and find other member-exclusive tools to help plan for residency. Get started. 

Confidential, Voluntary Questionnaire Developed to Capture Information

WE ARE MOVING THE NEEDLE! FROM 14% OF THE MEMBERSHIP PROVIDING INFORMATION AS OF JULY TO 16% TO DATE! The MSD Committee on Diversity, Equity, and Inclusion is working to support a diverse physician workforce and inclusive organizational culture. Prior to 2021, MSD did not collect racial, ethnic, and gender information about our members. As a starting point toward understanding and improving our membership diversity, your help is greatly appreciated in submitting this information. A brief, four-question questionnaire has been developed and will take less than a minute to complete. Your information will remain confidential, however, it will be used in aggregate to assess the diversity of our membership, how that correlates with the diversity of our leadership and to understanding the diversity of the physician workforce in Delaware. Access the questionnaire.

Due to Being Non-Sterile

Medline Industries is recalling the Hudson RCI Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution (Lot 3B085) due to being non-sterile. The affected lot passed sterility testing, however, another lot within the same cleaning cycle (Lot 3B087) failed sterility testing, exposing the affected lot to potential contamination. The Hudson RCI Addipak Unit Dose Vials is a pack of single use 0.9% Full Normal Saline Solution used during treatments, such as inhalation and irrigation therapy. It may be used with a non-ventilatory nebulizer to clean the lungs or for tracheal irrigation. For inhalation therapy, the saline solution restores moisture to the lungs, relieves congestion caused by colds or allergies, or dilutes bronchodilator (rescue inhaler) solutions that require dilution. For irrigation therapy, the saline solution is used for wound cleansing and flushing. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Alessandra Mariz

Alessandra Mariz has joined the MSD staff as the Volunteer Initiative Program (VIP) Health Services Coordinator. Alessandra activates Delaware residents who are enrolled in the state’s Health Care Connection (HCC) program, and also handles incoming specialty referrals to coordinate their visits with MSD’s network of VIP physicians and clinicians. Prior to joining MSD, Alessandra worked for Robert Half and has a strong background in customer service and patient relations. Alessandra is originally from Brazil and is fluent in Portuguese, Spanish, and English - we are excited to welcome her to the MSD family! 

Beebe Healthcare

Jessica McKeown

MSD spotlights members throughout the state, highlighting medical students, residents, and practicing colleagues, whether they are new to membership or have been a member over the years.

This week's spotlight is on Jessica McKeown, Medical Student at Philadelphia College of Osteopathic Medicine, class of 2025. Read more about Jessica.

If you would like to be featured in a future Member Spotlight, please contact Michelle Seymour, Manager of Membership.

Fabian P. Ngido, MD - Pediatric Hospitalist, Beebe Healthcare

Please join MSD in welcoming the newest members of the Medical Society of Delaware. As the third oldest medical society in the country, MSD has an amazing history. Thank you for taking part in our continued success!

The Latin phrase Rerum Cognoscere translates to learn, examine, or become aware of facts or things. In this section, we highlight measurable items of interest in health care from MSD, Delaware, the US, and the world.

CDC Director Rochelle P. Walensky, M.D., M.P.H. adopted the 2023-2024 Advisory Committee on Immunization Practices’ (ACIP) recommendations on annual influenza (flu) vaccination for everyone 6 months and older in the United States on June 27, 2023. There were small changes to the annual recommendations around flu vaccination, including an acknowledgement of the updated flu vaccine composition for the 2023-2024 flu season and a change in the recommendations for vaccination of people with egg allergies. Dr. Walensky’s adoption of the ACIP recommendations makes them official CDC policy, which have been published in the Morbidity and Mortality Weekly Recommendation Report August 23, 2023. Health care professionals should begin vaccinating patients according to CDC’s recommended timing, which remains the same as last season. Read the CDC Vaccine Recommendations for the 2023-2024 flu season.

Flu Vaccination Guidance for Children

Flu can be a serious threat to children. During a COCA call on August 31, 2023, presenters discussed flu prevention and treatment recommendations from the American Academy of Pediatrics and CDC. If you’ve missed it, this recording is a great update on vaccination, coadministration of flu vaccines, coverage, and health disparities.

The FDA has outlined the following brief guidelines for the updated COVID-19 vaccines to simplify the questions regarding whom should receive the vaccine and when: 

• Individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.  
• Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 vaccine received).  
• Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated authorized Moderna COVID-19 Vaccine. 

Vaccination will be available free for everyone through one of three methods.

• Most Private and government insurance plans - cost fully covered by insurance (receive through pharmacies, health care professionals)
• Uninsured, underinsured - cost covered through FQHCs; public health clinics; pharmacies; health care professionals via Delaware Immunization Program; and Walgreens, CVS, and pharmacies affiliated with ETrue North pharmacy network through Bridge Access Program.
• Children participating in CDC's Vaccines for Children Program - free from where they receive routine vaccinations.

 A full listing of vaccine locations is posted on www.vaccines.gov.

The national emergency and public health emergency (PHE) declarations related to the COVID-19 pandemic ended on May 11, 2023. The Centers for Medicare & Medicaid Services (CMS) has resources available, some of which have been updated based on recent action by Congress.

• Frequently Asked Questions: CMS Waivers, Flexibilities, and the End of the COVID-19 Public Health Emergency (Updated 5/12/2023).
• Provider-specific fact sheets for information about COVID-19 Public Health Emergency (PHE) waivers and flexibilities: https://www.cms.gov/coronavirus-waivers
• Acute Hospital Care At Home
• Loss of Medicaid or CHIP coverage
• FAQs on CMS Waivers, Flexibilities, end of COVID-19 PHE (May 4, 2023)

Updates will continue to be provided as we approach the end of the PHE. You are encouraged to regularly visit the CMS Emergencies Page for the most up to date information.

• Find COVID-19 Vaccines: https://www.vaccines.gov/
• No Cost COVID-19 Testing Locator can help people find current community and pharmacy partners participating in the Increasing Community Access to Testing (ICATT) program.
• FDA At-Home OTC COVID-19 Diagnostic Tests provides a list of all FDA-authorized at-home over-the-counter (OTC) COVID-19 diagnostic tests
• Federal website for information on navigating COVID: COVID.gov
• CDC Isolation and Precautions for People with COVID-19
• COVID-19 Therapeutics Locator
• CDC COVID Data Tracker
• CDC will report regional-level test positivity data from the National Respiratory and Enteric Virus Surveillance System (NREVSS)
• COVID-19 by County Community Level Check (# hospital admissions and beds used and total number of new cases)
• 2nd bivalent COVID-19 Vaccine Booster: Who Should Receive It?
• (Delaware) General Questions: call 211 or email DPHCall@delaware.gov or Vaccine@delaware.gov for vaccine-specific questions.
• Latest information on Delaware's response (testing, treatment, vaccination): de.gov/coronavirus (Updated 2/2023)